Fundraising FoxMican Technologies
Kyoto, JP · 3 known investors
Find your way into Mican Technologies
Sign up to see every warm intro you have to Mican Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mican Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
Founders & leadership
KM
Kazuo Miyazaki代表取締役CEO (Representative Director & CEO)Kazuo Miyazaki is founder and CEO of MiCAN Technologies, with over eight years of experience in drug discovery and safety testing using stem cell technologies. His background includes work in medicinal chemistry, drug discovery, and stem cell research.
KF
Kazuhisa Fushihara取締役CFO (Director & CFO)Kazuhisa Fushihara studied biochemistry at Tohoku University and enzyme characterization, then worked in R&D at Sumitomo Rubber developing printing blankets, golf ball materials, tire compounds, and sensors. He joined MiCAN Technologies as COO and CFO, managing business development, organizational development, and fundraising, and currently leads the company's safety testing business operations from Heidelberg; he holds 88 patents in his technical capacity.
Board
YN
Yasuhiro Natsume取締役 (Director)
Investors · 3
Frequently asked questions
- What does Mican Technologies do?
- MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
- Who are Mican Technologies's investors?
- Mican Technologies's investors include Kobe University Capital, OSAKA University Venture Capital, UntroD Capital.
- Where is Mican Technologies headquartered?
- Mican Technologies is headquartered in Kyoto, JP.